Introduction
HIV entry is mediated through envelope (Env) surface spikes composed of membrane-anchored gp41 subunits noncovalently bound to gp120 and oligomerized in a trimer. HIV enters cells by binding a CD4 receptor, undergoing conformational changes, then binding a co-receptor that triggers further changes mediating fusion and entry [1] [2] [3] . Neutralizing antibodies (NAbs) directly interfere with viral entry, and a small number of broadly neutralizing human monoclonal antibodies has been identified, enabling identification of potential vaccine targets [4, 5] . Table 1a lists amino acid positions that are critical functional or structural motifs in Env, and Table 1b lists key residues for NAb binding.
Neutralizing antibodies during natural infection
Antibody profiles in natural HIV infection offer clues for vaccine strategies. IgG and IgM antibodies arise within 8 days from infection, and mostly contribute to immune complexes [29] . Antibody responses to the V3 loop region come up relatively early, but are not neutralizing, and the V3 loop may be shielded in primary isolates [1] . NAbs with cross-reactive potential tend to appear later during infection, after serial rounds of immune evasion, retargeting the new variants, and escape from new responses [29] [30] [31] [32] . A multiplicity of epitopes, many yet undefined, contribute to neutralizing activity in individuals with broadly neutralizing sera [31, 33, 34] . CD4 binding site (CD4bs) antibodies are common and are often not neutralizing; however, in some cases they do have broad cross-neutralizing potential [31, 35, 36] . There is no particular antibody-specificity associated with individuals who naturally control infection, and they generally have lower titers of NAbs [37] .
The implications of natural responses for vaccine design
A basic strategy for testing the breadth of NAb responses involves comparing panels of sera from natural infection or vaccinated animals and individuals with panels of isolates [38, 39] . To organize these data into potentially meaningful patterns, we turned to the concept of a 'heat map' [40] . Heat maps display quantitative data, such as levels of neutralization, with a color intensity code, and arrange these levels in a rectangular array in which the two axes correspond to two different aspects of the data (e.g. antibodies on one axis and Envs on the other). The axes can be organized using standard clustering algorithms so that similar resistance/susceptibility profiles are brought together [40] , enabling shared reactivity patterns to be discerned. This scheme helped us to identify clade specificity in broad patterns of neutralization susceptibility and resistance [40, 41] . Although the genetic subtypes do not directly correspond to serotypes [42] , they do impact epitope variability and thus are related to antibody susceptibility patterns [40, 43, 44] (Fig. 1) , and subtype C infections elicit the most broadly cross-reactive NAbs [43] .
We have made a user-friendly web-based tool to facilitate clustering of antibodies or sera versus Envs (http:// www.hiv.lanl.gov/content/sequence/HEATMAP/heat map.html), testing the statistical robustness of clusters using bootstrap statistics to assess the effect of limited sampling within a hierarchical clustering strategy [41] . Other clustering algorithms can be used to organize immunological responses into clusters of like behaviors (e.g. we have begun to use k-means to organize heat maps). Similarly, other measures of statistical robustness could be incorporated when defining clusters (e.g. we have begun to incorporate intrinsic assay error based on experimental repeat data). Identifying statistically robust phenotypic clusters of similar susceptibility/resistance patterns can enable the identification of mutational sequence signatures that correlate with a shared susceptibility pattern [41] . Env sequences from patients who have particularly broadly reactive sera may inform vaccine design. These and other analytic approaches will be essential for interpreting the standardized panel data as everlarger numbers of standardized data sets accrue [36, 39, 51, 52] .
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Figure 1 Phylogenetic relationships and epitope diversity
The figure shows a maximum likelihood tree [45] of patient consensus sequences based on single genome amplified sequence sets from B or C subtype infections from patients sampled very early in infection (Fiebig stages 1-4) [46, 47] . These sequences were selected because early withinpatient consensus sequences are an excellent approximation of the transmitted virus [47] , which are the most relevant vaccine targets. Adjacent to each terminal branch on the tree are alignments of the core epitopes of the four most studied monoclonal neutralizing antibodies, illustrating patterns of within-clade and between-clade diversity. 4E10 is the most broadly reactive NAb. The direct contact residues for this antibody have been mapped to four amino acids on a helical face of its core binding peptide NWFDIT: W672, F673, I675, and T676 [48] and these amino acids are nearly perfectly preserved within the M group.
Targeting the epitopes of broadly neutralizing monoclonal antibodies
The four most intensely studied HIV-specific broadly NAbs were derived from people with a HIV subtype B infection; they are 2F5, 4E10, IgG1b12 and 2G12 [4, 5] (Table 1b) . These antibodies, alone or in combination, can block infection in animal models [53] [54] [55] [56] . They have been intensely studied to characterize their breadth and binding sites, to define common features of NAbs, and to explore the potential of forcing vaccine antigens into conformations that allow exposure of their epitopes. They are also used in therapeutics and strategies to prevent infection [57] . Because of their great value, other monoclonal NAbs are actively being sought and characterized [58] [59] [60] .
Neutralizing antibody targets
The membrane-proximal external region (MPER) is a likely vaccine target because several broadly NAbs are specific for this region, including 2F5 and 4E10 [4] . NAbs with these specificities are rare in human HIV infections and are difficult to induce by vaccines [27], although 4E10-like and 2F5-like specificities have recently been identified in HIV-infected individuals [31, 61] . Their rarity could result from common gp41 'cluster II' nonneutralizing antibodies blocking access to MPER-neutralizing epitopes [62] , tolerance resulting from selfmimicry as 2F5 and 4E10 are polyspecific and also react with cardiolipin and phosphatidylserine [63, 64] , or transience of exposure during prefusion conformational transitions [65] . In contrast, responses to the CD4bs are common, but often do not provide broadly neutralizing cross-protection. IgG1b12 is an exception; it is a CD4bs antibody that neutralizes many isolates, with a limited recognition of subtypes A and D [40] . Crystallography data provide a detailed view of the CD4bs region and of the IgG1b12 epitope [26] . The monoclonal 2G12 is unusual in that in recognizes a cluster of oligomannose sugars [23, 24, 66] . Figure 1 is a phylogenetic tree that illustrates typical genetic distances within and between subtypes, using representative acute infection Env sequences from subtypes B and C [46, 47] . Adjacent alignments show variation in core epitopes of the four cross-neutralizing monoclonal antibodies in the B and C subtypes; variation is clearly greater between subtypes than within subtypes. 4E10 is remarkably cross-reactive [40] , with moderate neutralizing potency against almost all variants tested, and its direct contact residues are highly conserved. The 4E10-binding motif xWFxI[S/T] [57, 58] is found in 95% of all M group sequences in the HIV database, and is conserved in all sequences in Fig. 1 . Such core conservation provides a minimal essential requirement for epitope cross-reactivity. In contrast, the frequent loss of the core epitopes of 2F5 and 2G12 in subtype C sequences (Fig. 1) contributes to their inability to neutralize C clade viruses [4, 40, 41, 43, 44] . C clade Envs typically lack a glycosylation site at position 295 (Fig. 1) , limiting 2G12 crossreactivity. Just reintroducing this glycosylation motif back into C clade viruses, however, has variable success in terms of restoring the epitope, indicating that the 2G12 epitope is also dependent on context [67] . The IgG1b12 core epitope has many contact points with scattered diversity, and some mutational patterns within the epitope are enriched in the C subtype.
Diversity in conserved epitopes
The conventional wisdom is that these four epitopes are conserved, but it is prudent to remember that they are only relatively conserved. The breadth of 4E10 neutralizing activity is the exception even among these most crossreactive NAbs, and even 4E10 cannot react with all variants [60] . To consider the implications of the levels of diversity shown in Fig. 1 , a study of epitope variation and crossreactivity in influenza is informative [68] . A simple antigenic distance measure (the fraction of amino acids altered within the dominant epitope) is a powerful predictor of influenza vaccine efficacy. When the antigenic distance in the dominant epitope reached approximately 20%, the vaccine efficacy became negative [68] . A 20% amino acid change is common even in the core binding regions of the most cross-reactive HIV NAbs (Fig. 1 ).
Variation and exposed epitope antigen design
Using monoclonals with a profound ability to neutralize the virus as a guide for vaccine antigen design has proven to be difficult [69] . As even the most cross-reactive NAbs HIV diversity and neutralizing antibodies Korber and Gnanakaran 411 The antibody tolerates Thr/Ser variation at position 676, and the 4E10-binding motif xWFxI[S/T] is highly conserved. Positions 671 and 673, designated 'x' are quite variable, but that variation does appear to affect 4E10s cross-neutralizing prowess. There are rare exceptions to 4E10 susceptibility; for example, in a virus from a subtype C-infected patient, 4E10 resistance was observed due to a change in F673L, whereas 2F5 epitope was maintained [49] . Neutralization by 2F5 antibody correlates with the presence of the LDKW motif at positions 663-666 [50] ; a K to S change is very common in the C clade. 2G12 requires a set of noncontiguous N-linked glycosylation motifs (of the pattern Nx[ST]), and three critical motifs are shown here [23, 24] (the glycosylation sites at positions 295, 332, 392). One or both of the critical glycosylation motifs are lost in the majority of the C clade sequences. Discontinuous positions from the IgG1b12 binding site [26] , the set listed in Table 1a , are included here, with the exception of the sites T257, Y384 and P386 as these sites were invariant. There are scattered IgG1b12 epitope substitutions throughout the B and C clades, with distinctive patterns of variants populating subsets of the C clade.
have relatively diverse core epitopes, cocktails of variants may be essential for eliciting cross-reactive breadth even in the neighborhood of relatively conserved epitopes. (As an alternative to a cocktail, one could at least use a consensus [70] to minimize the antigenic distance between circulating strains and vaccines within epitopes.) The failure or success of strategies to expose vulnerable epitopes is often judged by the cross-reactive breadth of the response to the modified exposed region, and based on a single strain. Thus some epitope-exposure strategies may have worked reasonably well, but the response was too narrow for the strategy to be considered of value. A logical alternative for epitope exposure strategies would be to first seek induction of potent neutralization of the autologous strain to assess exposure. If this is successful, then genetically engineer inclusion of select common variants within the exposed epitope for a cocktail design, with the goal of eliciting more complex polyclonal antibody-binding profiles to improve the chances for success when screening against a panel of diverse Envs.
We have selected a few examples from the many attempts to engineer vaccines targeting neutralizing epitopes to illustrate the concept of embracing diversity from the outset [71] [72] [73] [74] [75] . A novel antigen-design strategy that has shown some success displays the 2F5 core peptide (ELDKWA) in the context rhinovirus chimeras selected from a combinatorial library by 2F5 binding [71] . The sera raised in guinea pigs vaccinated with these chimeric antigens have neutralizing activity, with a somewhat greater capacity to cross-react with the C subtype consensus variant (ALDSWA) than 2F5, probably due to the polyclonal nature of the response. A logical next exploratory step would be site-directed mutagenesis deliberately introduce common variants like ALDSWA to determine if this could enhance the cross-reactive coverage of the response. Similarly, strategies to lock the MPER in a prefusion intermediate form [65, 73] could benefit from engineering common regional variants into target epitopes. Another interesting candidate immunogen selectively exposes the IgG1b12 epitope in a subtype B virus TA1 R3A [75] . The IgG1b12-binding surface is considered conformationally conserved [75] , but IgG1b12 epitope is sufficiently variable (Fig. 1 ) that a cocktail including select combinations of common variants on this surface might induce a greater breadth of response. Given that only common natural variants would be included, such substitutions may be tolerated. Variants can impact structurally distant sites in ways that are hard to predict [49, 76] , potentially limiting approaches that attempt to address local variation.
From subunits to trimers: seeking more natural conformations of the envelope
The first HIV vaccine human efficacy trial used a gp120 subunit vaccine; antibodies were induced, but they were not cross-reactive NAbs, and the vaccine did not confer protection or reduce the incidence of HIV-1 infection [77] . Additional neutralization studies confirmed that soluble monomeric gp120 is a poor antigen for generating cross-reactive NAbs against primary isolates [78] . Thus, researchers began exploring strategies to create vaccine antigens that adopt a more relevant natural form of Env. The noncovalent association between the gp120 and gp41 proteins is labile, making it necessary to modify Env to stabilize soluble trimers [79, 80] . Disruption of the gp120-gp41 cleavage site by mutagenesis results in uncleaved gp140 proteins can result in stable trimers [72, 81] . Other approaches introduce trimer-stabilizing motifs [82, 80] , or allow cleavage to occur, then link gp120 and gp41 through a genetically engineered intermolecular disulfide bond [83] .
The implications of diversity for timers
Although soluble trimeric Envs are better than their monomer counterparts at inducing NAbs, the breadth of response to these immunogens is still too narrow [64, 83] . Given the level of diversity between HIV Env isolates ( Fig. 2) , this is not surprising. Thus including cocktails of variant Envs in HIV vaccines [84] [85] [86] may not only be desirable, it may be essential, despite reasonable concerns regarding costs and complexity of cocktail design strategies. Cocktail strategies are further motivated by the observation that neutralizing breadth only begins to appear later in infection after diversity has begun to accrue [29] [30] [31] [32] . Vaccine cocktails have shown promising enhancement of breadth [84] [85] [86] . In next sections we will explore the extent of local variation throughout the gp120 structure, and discuss the possibility of improving potential B cell epitope diversity coverage using a computational strategy to design proteins for cocktails.
The diversity of structurally defined regions
To illustrate the extent of local variation throughout gp120, a structure-based evaluation of sequence variation within discontinuous 'epitope-like' spatially proximal clusters was performed. The sequence variation between either the B or C consensus or a natural B strain, and sets of B and C subtype transmission sequences (those included in Fig. 1) was assessed for each cluster of 10 amino acids based on the contact profile obtained from long-time molecular dynamics simulations with explicit solvent. We selected 10 amino acids for our cluster size as an intermediate 'epitope-like' value -the actual size of a typical B cell epitope depends on one's perspective. Structures of the antigen-antibody interface show that at least 15 amino acids can be considered to be part of each epitope [87] , whereas functional approaches typically identify core epitopes involving four to eight key residues [88] . In Fig. 2a , for each of the 395 structurebased clusters in gp120, the fractions of sequences that match the B consensus are shown, ordered from the most to least conserved clusters. The fractions that differ by no more than 10% or 20%, respectively, are shown in the next two panels. The fractions of clusters with perfect coverage drop off rapidly, even within a subtype, but between clades the drop-off is severe. Figure 2b shows a summary of the total fractions of matches. Just over 20% of clusters match HXB2 in the B clade alignment, whereas only 12% match HXB2 in the C clade. With this low level of shared sequence in epitope-sized clusters, vaccines would be expected to frequently fail to elicit cross-reactive NAbs, although in some cases structural mimicry may allow cross-reactivity in the face of apparent diversity. Whereas within-subtype coverage is about twice as extensive as between-subtype coverage, both are typically low, which would make it difficult to distinguish distinct behaviors between subtypes when testing small panels of Env proteins.
As mentioned earlier, sequence mismatches of 20% or more within an epitope is a potentially critical cut-off [68] . Thus in Fig. 3 we display diversity in a threedimensional backbone of gp120 structure using a color code to indicate the fraction of individuals in the alignment that share more than 80% of the amino acids in an epitope-sized cluster with either the B or C consensus, for clusters centered on every position in the structure. The sequence variation within local clusters is more dramatic when compared between subtypes than within HIV diversity and neutralizing antibodies Korber and Gnanakaran 413 Figure 2 Variation in of epitope-like domains A local domain of 10 proximal amino acids was calculated centered on every position in the 395 amino acid stretch of gp120 included in the structure (which lacks the N and C-terminal regions) described in the legend to Fig. 3 . For part (a), 395 mini-alignments, including only the positions included in each of the 395 10 amino acid local domains, were created from the B and C clade transmitted virus sequence alignment described in Fig. 1 . The B consensus sequence was compared separately with B and C clade transmitted sequence sets, and the frequency of identities, 90% matches, and 80% matches was calculated for each of 395 local regions. The most to least conserved regions were plotted left to right. Local regions that are highly conserved are relatively rare, and the frequency of well matched sequences rapidly drops off. Part (b) shows the overall fraction of perfectly conserved, 90% conserved, and 80% conserved local domains for either the B and C clade transmitted sequence sets when compared with the B or C consensus, a natural B clade strain (HXB2). Inter-clade coverage drops off dramatically, as seen in both parts (a) and (b), and HXB2 coverage of local regions is substantially reduced relative to consensus coverage.
subtypes. A portion of the interior is conserved above the 80% level in most strains, whereas the hypervariable variable loops V1, V2, V4 and V5 exhibit extreme population diversity, and so would be unlikely to elicit crossreactive antibody responses. The outer domain, including the a2 helix and V4 loop, exhibits significant sequence variation and is clearly under selective pressure, despite being part of the silent face of the gp120. This region is expected to be exposed in a functional trimer, though heavily glycosylated, regardless of whether Env is bound to CD4.
Contending with diversity
With our colleagues we have developed a strategy to design vaccine antigens that for a given cocktail size in combination provide the nearly optimal coverage for contiguous T cell epitopes. Our strategy involved taking a large set of global sequences, generating recombinants in silico (called mosaics) that resemble natural proteins, and utilizing a computational tool called a genetic algorithm to design a vaccine cocktail that maximized coverage of potential T cell epitopes [93] . Our first mouse study of mosaic Env protein cocktails indicated that they The fraction of sequences that exhibit less or equal to a 20% mismatch within an epitope-like spatial cluster are shown when (a) the B consensus is compared with B acute sequences, (b) B consensus was compared with C acute sequences, (c) C consensus compared with C acutes, and (d) C consensus compared with B acutes. The fractions are graphically mapped on a gp120 core backbone that corresponds CD4-liganded HIV-1 YU-2 gp120 structure [89] with modeled V1V2 and V3 loops added as described previously [90] . The loops are shown only to illustrate the regional sequence variation and they do not represent the actual dominant conformation. The color gradient is used to capture the sequence invariance with blue indicating conservation, with most sequences having less than a 20% mismatch, and red indicating high diversity, with most sequences having a 20% mismatch or more within the spatial cluster. The spatial clusters were gathered from the contact matrix obtained from the long timescale molecular dynamics simulations of gp120 of YU2 strain with modeled loops in explicit aqueous solvent [91, 92] . For each residue in the simulated structure a spatial cluster was generated such that it contained the top ten closest contact amino acids that fall within the average C-alpha distance cutoff of 10Å . A total of 395 such spatial clusters were generated corresponding to the total number of residues in the simulated gp120 structure.
were highly immunogenic and stimulated T cells with significantly greater cross-reactive breadth than cocktails of natural strains [84] . The 10 amino acid discontinuous epitope length regions used to explore variability potential B cell epitopes in Figs 2 and 3 could be similarly used to design potential B cell epitope coverage-optimized mosaic protein sets. For B cell mosaics, an Env alignment accompanied by the list of the 10 closest positions for every amino acid in the structure (known and modeled structure) would be the input. The genetic algorithm would use the same strategy as was applied for T cell mosaics, in-silico recombination with an iterative selection process to optimize potential epitope coverage in candidate mosaic cocktails, but in this case the selection criteria would be coverage of the discontinuous epitopelike fragments. We are currently investigating the feasibility of such an approach. Mosaics closely resemble natural strains, and our T cell optimized mosaic Envs were well expressed and highly immunogenic [94] . Mosaics by design are assembled from common mutational solutions that the virus itself favors while evolving to balance fitness constraints with immune escape, so it is plausible that a cocktail based on this approach will elicit NAbs with greater breadth. Part of the challenge will be to elicit antibodies that target exposed epitopes on natural primary isolates of the virus, perhaps in regions of Env that drive the NAb response in infected individuals. The typical overall poor immunogenicity of these epitopes in a vaccine context would likely require that Env mosaics with other creative approaches (e.g. novel adjuvants, native Env structures) in order to be successful.
Conclusion
HIV is an extraordinarily variable virus, and even the most conserved NAb epitopes are affected by its diversity. Considering the natural diversity of the virus from the outset for HIV design, at a minimum using consensus sequences, or better, logically selected variants in a cocktail, may be essential. Polyvalent vaccine cocktails are an expensive alternative in a design pipeline, without them we may be setting ourselves up for failure.
